The federal Department of Health and Human Services is proposing to roll back an Obama-era policy intended to protect transgender people from discrimination in health care.
Better, Safer Sex: On the Hunt for a Condom People Will Actually Like
Polish towns go 'LGBT free' ahead of bitter European election campaign
UK: Raising the equality flag
New data analysis shows that LGBT men and women aged 50+ have poorer self-rated health and are more likely to have other conditions that impact their health and wellbeing. This analysis has, for the first time, demonstrated strongly that these differences persist even after accounting for other factors.
US: Ocasio-Cortez slams Gilead over HIV drug prices: 'People are dying for no reason'
US: Gilead CEO insists federal government patent for HIV prevention pill Truvada is invalid
US: Gilead is accused of cutting anti-competitive deals to extend profit on HIV drug combinations
Combination drug “cocktails” to treat HIV infection are an important part of patients’ routine, allowing them to reduce the number of pills they must take each day. But the lifesaving tablets also were the focus of anti-competitive schemes by the nation’s leading HIV drug manufacturer, Gilead Sciences, according to a consumer lawsuit filed Tuesday.
Pakistan: In K-P, transgender people get HIV-AIDS testing kits
The Thin Line Between Surgery and Mutilation
China: Transgender people risk their lives with dangerous self-surgery
US: Official Statement Responding to Gilead Sciences’ Announcement on a Generic Version of Truvada
Even their announcement today leaves Gilead with exclusive rights to Truvada as PrEP for another 15 months and Teva as the only generic manufacturer on the U.S. market. This will do little to reduce the price in a way that will increase access and PrEP4All remains suspicious of the terms and lack of transparency surrounding the Teva settlement.